AMACR overexpression acts as a negative prognostic factor in oral squamous cell carcinoma.

about

AMACR overexpression acts as a negative prognostic factor in oral squamous cell carcinoma.

Item

http://www.wikidata.org/entity/Q55400470

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

AMACR overexpression acts as a ...... oral squamous cell carcinoma.

@en

AMACR overexpression acts as a ...... oral squamous cell carcinoma.

@nl

type

Item

label

AMACR overexpression acts as a ...... oral squamous cell carcinoma.

@en

AMACR overexpression acts as a ...... oral squamous cell carcinoma.

@nl

prefLabel

AMACR overexpression acts as a ...... oral squamous cell carcinoma.

@en

AMACR overexpression acts as a ...... oral squamous cell carcinoma.

@nl

P1476

AMACR overexpression acts as a ...... oral squamous cell carcinoma.

@en

P2093

Chang-Ta Chiu

http://www.w3.org/2001/XMLSchema#string

Hong-Lin He

http://www.w3.org/2001/XMLSchema#string

Min-Te Chang

http://www.w3.org/2001/XMLSchema#string

Shih-Lun Chang

http://www.w3.org/2001/XMLSchema#string

Tzu-Ju Chen

http://www.w3.org/2001/XMLSchema#string

Ying-En Lee

http://www.w3.org/2001/XMLSchema#string

Yow-Ling Shiue

http://www.w3.org/2001/XMLSchema#string

P2860

α-Methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence

Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review)

Purification and properties of an alpha-methylacyl-CoA racemase from rat liver

α-Methylacyl-CoA racemase (AMACR) in gastric cancer: correlation with clinicopathologic data and disease-free survival.

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.

α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC

Alpha-methylacyl-CoA racemase--an 'obscure' metabolic enzyme takes centre stage.

AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis.

P304

638-644

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/IJMS.23291

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29725255

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

P932

5930466

http://www.w3.org/2001/XMLSchema#string